Aspirin and prevention of preeclampsia. Position statement of the use of low-dose aspirin in pregnancy by the Australasian Society for the Study of Hypertension in Pregnancy.
1. A heterogeneous group of randomized trials have been conducted using low-dose aspirin to prevent preeclampsia. The results do not support widespread use of low-dose aspirin to prevent preeclampsia. 2. On the basis of existing literature, it is reasonable to use prophylactic low-dose aspirin from early pregnancy in the following groups: (i) Women with prior fetal loss after the first trimester, with placental insufficiency (ii) Women with severe fetal growth retardation in a preceding pregnancy either due to preeclampsia or unexplained (iii) Women with severe early-onset preeclampsia in a previous pregnancy necessitating delivery at or before 32 weeks' gestation. 3. On the basis of existing literature, it is recommended that aspirin not be used in the following groups: (i) Healthy nulliparous women (ii) Women with mild chronic hypertension (iii) Women with established preeclampsia. 4. The data are sufficient to support further trials in more homogeneous select subgroups of women considered at risk of developing preeclampsia.
Brennecke
S P
SP
Department of Perinatal Medicine, Royal Women's Hospital, Melbourne, Australia.
Brown
M A
MA
Crowther
C A
CA
Hague
W M
WM
King
J
J
McCowan
L
L
Morris
J
J
North
R
R
Pattison
N
N
Tippett
C
C
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018579:Patient Selection; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D011322:Primary Prevention / Q000379:methods; D016032:Randomized Controlled Trials as Topic
D001241:Aspirin